- Home
- DAWN vs VIRT Comparison
DAWN vs VIRT Comparison
Compare DAWN & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DAWN | VIRT |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.8M | 2.8B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DAWN | VIRT |
|---|---|---|
| Price | $9.28 | $33.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $26.56 | ★ $41.43 |
| AVG Volume (30 Days) | ★ 3.0M | 876.2K |
| Earning Date | 11-04-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.86% |
| EPS Growth | N/A | ★ 132.69 |
| EPS | N/A | ★ 4.62 |
| Revenue | $133,672,000.00 | ★ $2,694,104,000.00 |
| Revenue This Year | $15.51 | N/A |
| Revenue Next Year | $49.99 | N/A |
| P/E Ratio | ★ N/A | $7.27 |
| Revenue Growth | 31.11 | ★ 41.05 |
| 52 Week Low | $5.64 | $31.89 |
| 52 Week High | $13.53 | $45.77 |
Technical Indicators
Market Signals| Indicator | DAWN | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 43.44 |
| Support Level | $8.13 | $33.30 |
| Resistance Level | $10.47 | $34.52 |
| Average True Range (ATR) | 0.62 | 0.86 |
| MACD | 0.08 | -0.16 |
| Stochastic Oscillator | 53.50 | 28.99 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.